View online Forward to a friend   |   Facebook   |   Twitter
Pharmaceutical Outsourcing
Featured Articles   |   Featured Partners   |   Videos   |   Industry News   |   Events
April 06, 2021
learn more
Newsletter Sponsor
  Ajinomoto Bio-Pharma Services - What Do You Want To Make?

Ajinomoto Bio-Pharma Services offers comprehensive CDMO capabilities for small and large molecule APIs, including high potency, ADCs and oligonucleotides. Our global network provides the adaptive solutions, responsive service, trusted partnership and peace of mind you’ve come to rely on. We have the Power To Make your every challenge our own and share your unwavering tenacity and dedication from pre-clinical programs through to commercial successes. Together, we have the Power To Make.

more info

» Industry News
 
more news
» Featured Articles
ICH E6(R3): Setting the Stage for the Future of Clinical Trials
Without clear-cut evidence that clinical trial results are reliable – and that treatments are both safe and effective - billions of dollars and years of hard work are rendered moot. Yet as trials grow... read more »
Adapting Bioprocessing to Meet the World’s Changing Demands
Among the many lessons learned during the COVID-19 pandemic is the need for large biopharma companies to be able to pivot quickly to meet emerging threats and demand for novel products. While this ... read more »
more articles
 
» Featured Announcements
Solid State Research and Development Services
Sponsored by Eurofins CDMO
Eurofins CDMO provides expertise and services in physicochemical characterization of API and ... read more »
more articles
 
» Featured Video
learn more
  On-Demand Webinar: NAb-bed Again! – Avoiding Pitfalls During Immunogenicity Studies
In this webinar you’ll learn selection of the optimal methodology and cell line, utilizing appropriate controls, and choosing the right CRO partner for your immunogenicity studies. read more »

more videos
 
» Featured Whitepaper
The 10 Commandments for Investigational Medicinal Products in EU
Sometimes it is good to go back to basics, knowing that everything is not carved instone with early phase IMPs. This white paper does not impose ... read more »
more articles
 
This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription |  Unsubscribe  | Contact Pharmaceutical Outsourcing


Pharmaceutical Outsourcing
164 Townsend St. Unit 2
San Francisco, CA 94107 USA